Leto Laboratories specializes in cutting-edge protein technologies and drug development, focusing on oncology, peptide, and cytokine therapies. The company operates in the biotechnology and pharmaceutical markets, serving clients ranging from research institutions to pharmaceutical companies. Leto Laboratories leverages proprietary technology platforms such as LetoFOLD for protein refolding, along with advanced screening, purification, and engineering design techniques. Its business model revolves around developing first-in-class drugs and high-potential early-stage discoveries, generating revenue through partnerships, licensing agreements, and direct sales of its proprietary technologies and products. The company's team comprises experienced professionals with expertise in both local and international markets, ensuring a robust pipeline of innovative solutions.

Keywords: protein technologies, drug development, oncology, peptide therapies, cytokine therapies, LetoFOLD, screening, purification, engineering design, biotechnology.